Clinical Trial Detail

NCT ID NCT01849588
Title Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
Recruitment Terminated
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.